A group of Northern Irish researchers have come up with a new treatment that promises to help those who are suffering from cystic fibrosis.
Researchers from Queen's University Belfast, the University of Ulster and the Belfast Health and Social Care Trust, developed the new medicine, known as VX-770 which will help treat cystic fibrosis among those who suffer from a genetic mutation known as Celtic Gene.
However the researchers said that the medicine could also be used among other cystic fibrosis patients since the basic defect in the illness can be treated using the medicine. The researchers added that those who had taken the drug displayed improved lung function and reduction in the number of flare-ups of the disease.
"It is the first to show that treating the underlying cause of Cystic Fibrosis may have profound effects on the disease, even among people who have been living with it for decades", Queen's University Belfast's Stuart Elborn said.